Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1519 results found. Search for [ Pharma industry ]

Results 1160 to 1180 of 1519
PTI
New Delhi, June 3, 2013
Drug firm Ranbaxy Laboratories on Monday declined to comment on the reports from Brussels that European Union anti-trust regulators may fine the domestic pharma company for allegedly blocking of entry of cheaper generic medicines in the market.


L Kishore Babu
June 3, 2013
Although the industry had time until 2005 to conform to the new patent regime, we consciously avoided short-term temptations,  says L. Kishore Babu, CFO, Divi's Labs.


Swati A. Piramal
June 4, 2013
Swati A. Piramal, Vice Chairperson, Piramal Enterprises says integrity is vital in any health-care business, where we are saving lives when patients use our medicines.


E. Kumar Sharma
June 15, 2013
A close look at the Indian pharmaceutical industry shows a complicated regulatory structure and a web of entities at the central and state levels tasked with monitoring the sector. The regulator is now getting a makeover but better enforcement and safer medicines are yet a chimera.


Kiran Mazumdar-Shaw
June 18, 2013
The issuing of manufacturing licences should be strictly regulated and the frequency of spot audits stepped up along with severe penalties for non-compliance, writes Biocon CMD Kiran Mazumdar-Shaw.


Chaitanya Kalbag
June 5, 2013
Fortis Healthcare Executive Chairman Malvinder Singh, while rebutting Japanese firm Daiichi Sankyo's charges, says the company failed in growing the Ranbaxy business.


E. Kumar Sharma and Chaitanya Kalbag
June 4, 2013
The pharma major is still to get its Paonta Sahib and Dewas units back on track for inspection and approval by the FDA so that it can resume supplies to the US from these facilities.


Dipak Mondal & Tanvi Varma
June 6, 2013
Mutual funds have changed the way Indians invest. Money Today looks at how they performed in 2012-13.


E. Kumar Sharma
May 23, 2013
Ten days after the US Department of Justice announced that Ranbaxy had pleaded guilty and agreed to pay $500 million as settlement for having engaged in manufacturing violations, the battle lines have been drawn between the new and old managements of the company.


BT Online Bureau
Mumbai, May 23, 2013
Shares of the company opened on a weak note and further tanked 9.3 per cent to Rs 391 on the BSE. At NSE, the stock tumbled 9.37 per cent to Rs 390.65.


PTI
New Delhi, May 22, 2013
Drug maker Ranbaxy's Japanese promoters on Wednesday blamed the company's former Indian owners for concealing and misrepresenting critical information about US investigation into sale of adulterated drugs, and said it will pursue legal remedies.


PTI
New Delhi, May 17, 2013
The Department of Pharmaceuticals has notified the Drugs (Prices Control) Order 2013, under which prices of 348 medicines have been brought under price control.


PTI
New Delhi, May 16, 2013
Prices of 348 medicines, including life saving drugs, will be cheaper soon by up to 80 per cent as the new Drug Price Control Order has come into effect.


BT Online Bureau
Mumbai, May 14, 2013
Shares of Ranbaxy Laboratories recovered from early losses and settled nearly 4 per cent higher on hopes that settlement of its long lawsuit in the US would be positive for drug maker the in the long term.


E Kumar Sharma
May 14, 2013
Analysts who have examined the just announced $500 million settlement of the case in the United States see it as more of a company-specific issue. But what cannot be ignored is the seriousness of the case and the sheer size of the settlement.


BT Online Bureau
Mumbai, May 3, 2013
In a highly volatile trade, the BSE benchmark Sensex on Friday fell by 160 points on profit-booking in interest-sensitive banking, auto and realty stocks as RBI adopted a \"hawkish\" stance in its monetary policy 2013-14 that overshadowed its 0.25 per cent cut in repo rate.


E. Kumar Sharma
May 6, 2013
India is the world's third-largest pharmaceuticals market in terms of volumes, but competition is stiff to grab a slice of the rapidly growing business. Several small pharma companies are making a big difference in niche areas of health-care.


PTI
Mumbai, April 13, 2013
The BSE barometer Sensex resumed the week slightly higher at 18,455.80 and moved up further to 18,599.14 on select buying. However, it declined immediately to a seven-month low to 18,173.31 before ending the week at 18,242.56, showing a fall of 207.67 points.


PTI
New Delhi, April 11, 2013
Painting a favourable picture for the domestic pharmaceutical companies, ICRA said balance sheets of major pharmaceutical companies remain strong and provide adequate room for fund raising if required.


E. Kumar Sharma
April 13, 2013
The Supreme Court decision on Glivec sets the tone for other patent disputes and puts global drugmakers on the back foot.


PAGES 59 OF 76  5657585960